A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
Clinical trial NCT00390650 · COMPLETED
Trial details
- NCT number
- NCT00390650
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-11-01
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.